Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).
Alfasigma to buy Intercept Pharmaceuticals for $794m
The proposed business combination will bolster Alfasigma’s gastrointestinal and hepatology portfolio. Credit: Peakstock/Shutterstock.com. Italian company Alfasigma has signed a definitive agreement for the acquisition of all
September 27, 2023